ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 272 filers reported holding ALKERMES PLC in Q2 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,365,245 | -18.8% | 691,369 | -9.2% | 0.00% | 0.0% |
| Q2 2023 | $23,837,734 | -29.7% | 761,589 | -36.7% | 0.00% | -33.3% |
| Q1 2023 | $33,899,096 | +84.5% | 1,202,522 | +71.0% | 0.00% | +50.0% |
| Q4 2022 | $18,378,169 | +30.8% | 703,336 | +11.8% | 0.00% | 0.0% |
| Q3 2022 | $14,053,000 | -7.7% | 629,266 | +23.1% | 0.00% | 0.0% |
| Q2 2022 | $15,226,000 | +28.3% | 511,132 | +13.3% | 0.00% | +100.0% |
| Q1 2022 | $11,870,000 | +50.3% | 451,123 | +32.8% | 0.00% | 0.0% |
| Q4 2021 | $7,900,000 | -15.5% | 339,613 | +12.0% | 0.00% | 0.0% |
| Q3 2021 | $9,354,000 | +16.3% | 303,333 | -7.5% | 0.00% | 0.0% |
| Q2 2021 | $8,045,000 | +35.6% | 328,052 | +3.3% | 0.00% | 0.0% |
| Q1 2021 | $5,933,000 | -14.2% | 317,621 | -8.4% | 0.00% | 0.0% |
| Q4 2020 | $6,918,000 | +31.6% | 346,718 | +9.3% | 0.00% | 0.0% |
| Q3 2020 | $5,256,000 | -8.6% | 317,223 | +7.1% | 0.00% | 0.0% |
| Q2 2020 | $5,749,000 | -1.1% | 296,276 | -26.5% | 0.00% | 0.0% |
| Q1 2020 | $5,814,000 | -38.4% | 403,183 | -12.9% | 0.00% | 0.0% |
| Q4 2019 | $9,440,000 | +46.1% | 462,716 | +39.7% | 0.00% | 0.0% |
| Q3 2019 | $6,461,000 | -35.4% | 331,126 | -25.3% | 0.00% | -50.0% |
| Q2 2019 | $9,996,000 | -37.2% | 443,521 | +1.6% | 0.00% | 0.0% |
| Q1 2019 | $15,927,000 | +135.4% | 436,484 | +90.4% | 0.00% | +100.0% |
| Q4 2018 | $6,766,000 | -46.1% | 229,265 | -22.4% | 0.00% | -50.0% |
| Q3 2018 | $12,543,000 | -19.3% | 295,527 | -21.7% | 0.00% | 0.0% |
| Q2 2018 | $15,541,000 | -42.9% | 377,604 | -19.5% | 0.00% | -50.0% |
| Q1 2018 | $27,194,000 | +3.7% | 469,165 | -2.1% | 0.00% | 0.0% |
| Q4 2017 | $26,232,000 | -20.0% | 479,296 | -25.7% | 0.00% | -20.0% |
| Q3 2017 | $32,803,000 | +15.0% | 645,200 | +31.1% | 0.01% | 0.0% |
| Q2 2017 | $28,530,000 | +19.5% | 492,162 | +20.6% | 0.01% | -16.7% |
| Q1 2017 | $23,878,000 | +1.5% | 408,161 | -3.6% | 0.01% | +20.0% |
| Q4 2016 | $23,531,000 | +58.6% | 423,368 | +34.2% | 0.01% | +66.7% |
| Q3 2016 | $14,833,000 | -0.4% | 315,393 | -8.4% | 0.00% | 0.0% |
| Q2 2016 | $14,887,000 | +19.8% | 344,482 | -5.2% | 0.00% | 0.0% |
| Q1 2016 | $12,425,000 | -69.9% | 363,373 | -30.1% | 0.00% | -70.0% |
| Q4 2015 | $41,254,000 | +45.0% | 519,695 | +7.2% | 0.01% | +42.9% |
| Q3 2015 | $28,452,000 | +20.6% | 484,965 | +32.2% | 0.01% | -12.5% |
| Q2 2015 | $23,593,000 | +12.6% | 366,709 | +6.7% | 0.01% | +14.3% |
| Q1 2015 | $20,946,000 | +13.4% | 343,557 | +8.9% | 0.01% | 0.0% |
| Q4 2014 | $18,473,000 | +36.1% | 315,437 | -0.4% | 0.01% | +75.0% |
| Q3 2014 | $13,571,000 | -36.3% | 316,548 | -25.2% | 0.00% | -42.9% |
| Q2 2014 | $21,293,000 | +24.5% | 423,055 | +9.1% | 0.01% | +16.7% |
| Q1 2014 | $17,097,000 | -8.6% | 387,775 | -15.7% | 0.01% | -14.3% |
| Q4 2013 | $18,698,000 | +35.0% | 459,866 | +11.6% | 0.01% | +16.7% |
| Q3 2013 | $13,851,000 | -40.1% | 412,003 | -48.9% | 0.01% | -40.0% |
| Q2 2013 | $23,130,000 | – | 806,518 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |